Reyes, H. D., Carlson, M. J., Devor, E. J., Zhang, Y., Thiel, K. W., Samuelson, M. I., . . . Leslie, K. K. (2016). Downregulation of FOXO1 mRNA levels predicts treatment failure in patients with endometrial pathology conservatively managed with progestin-containing intrauterine devices. Gynecologic Oncology, 140(1), 152. https://doi.org/10.1016/j.ygyno.2015.10.023
Chicago Style (17th ed.) CitationReyes, Henry D., et al. "Downregulation of FOXO1 MRNA Levels Predicts Treatment Failure in Patients with Endometrial Pathology Conservatively Managed with Progestin-containing Intrauterine Devices." Gynecologic Oncology 140, no. 1 (2016): 152. https://doi.org/10.1016/j.ygyno.2015.10.023.
MLA (9th ed.) CitationReyes, Henry D., et al. "Downregulation of FOXO1 MRNA Levels Predicts Treatment Failure in Patients with Endometrial Pathology Conservatively Managed with Progestin-containing Intrauterine Devices." Gynecologic Oncology, vol. 140, no. 1, 2016, p. 152, https://doi.org/10.1016/j.ygyno.2015.10.023.